CpG 7909: Coley began a European Phase I/II trial of weekly doses of CpG 7909 as a monotherapy in melanoma patients. CpG 7909 also is in Phase I testing in comb

Coley Pharmaceutical Group Inc., Wellesley, Mass.
Product: CpG 7909

Read the full 100 word article

How to gain access

Continue reading with a
two-week free trial.